Christophe Van de Wiele
发表
Filip Devos,
Dominique Vlieghe,
Andrew Kelly,
2004,
Cancer biotherapy & radiopharmaceuticals.
André Vandierendonck,
Ingeborg Goethals,
Rudi Dierckx,
2004,
Nuclear medicine communications.
Roger Lecomte,
Timothy J. McCarthy,
Francesco Scopinaro,
2003,
Disease markers.
Steven Staelens,
Marc Peeters,
Patrick Pauwels,
2011,
The Journal of Nuclear Medicine.
Ingeborg Goethals,
Guido Slegers,
Christophe Van de Wiele,
2004,
The American journal of psychiatry.
Ingeborg Goethals,
Guido Slegers,
Christophe Van de Wiele,
2003,
International journal of radiation oncology, biology, physics.
Patrick Pauwels,
Ingeborg Goethals,
Christophe Van de Wiele,
2008,
Journal of Nuclear Medicine.
Andreas Otte,
Ingeborg Goethals,
Christophe Van de Wiele,
2004,
Journal of neurotrauma.
Marc Peeters,
Christophe Van de Wiele,
C. Van de Wiele,
2009,
Cancer biotherapy & radiopharmaceuticals.
Use of 18F-FDG PET to Predict Response to First-Line Tuberculostatics in HIV-Associated Tuberculosis
Alex Maes,
Mike Sathekge,
Christophe Van de Wiele,
2011,
The Journal of Nuclear Medicine.
Yves D'Asseler,
Kathelijne Peremans,
Christophe Van de Wiele,
2012,
The Journal of Nuclear Medicine.
Fréderic Duprez,
Katrien Bonte,
Christophe Van de Wiele,
2011,
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
Christophe Van de Wiele,
C. Van de Wiele,
R. Dierckx,
2009,
European Journal of Nuclear Medicine and Molecular Imaging.
Alex Maes,
Mike Sathekge,
Christophe Van de Wiele,
2013,
Seminars in nuclear medicine.
Evelien Wynendaele,
Frederick Verbeke,
Christophe Van de Wiele,
2017,
Front. Neurosci..
Debby Laukens,
Christophe Van de Wiele,
D. Laukens,
2013,
Molecular imaging.